Corvus Pharmaceuticals, Inc.
(CRVS - NASDAQ)
15,92 USD
📋 Profilo Aziendale

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies.

|